Terms: = Kidney tumors AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
23 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Is chest imaging needed as part of pT1a renal cell carcinoma surveillance after surgical resection?
Charles D; Fitzgerald J; Landowski T; Cooper B; Yong R; Everett R; See W; Jacobsohn K; Johnson S; Langenstroer P
Urol Oncol; 2024 Jan; 42(1):23.e1-23.e4. PubMed ID: 38040536
[TBL] [Abstract] [Full Text] [Related]
3. Rapamycin and rapalogs for tuberous sclerosis complex.
Sasongko TH; Kademane K; Chai Soon Hou S; Jocelyn TXY; Zabidi-Hussin Z
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011272. PubMed ID: 37432030
[TBL] [Abstract] [Full Text] [Related]
4. Retroperitoneoscopic partial nephrectomy using a 980/1470-nm dual-diode laser for small exophytic renal tumors.
Dong J; Xu W; Liu G; Xie Y; Qiao Y; Ji Z
Lasers Med Sci; 2022 Feb; 37(1):471-477. PubMed ID: 33713255
[TBL] [Abstract] [Full Text] [Related]
5. Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort.
Tonning Olsson I; Brinkman TM; Hyun G; Banerjee P; Mulrooney DA; Huang IC; Green DM; Srivastava D; Robison LL; Hudson MM; Krull KR
J Cancer Surviv; 2019 Aug; 13(4):570-579. PubMed ID: 31243647
[TBL] [Abstract] [Full Text] [Related]
6. Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Büttner F; Winter S; Rausch S; Hennenlotter J; Kruck S; Stenzl A; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
BMC Med; 2018 Jul; 16(1):108. PubMed ID: 29973214
[TBL] [Abstract] [Full Text] [Related]
7. Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.
Zhao F; Cella D; Manola J; DiPaola RS; Wagner LI; Haas NSB
Support Care Cancer; 2018 Jun; 26(6):1889-1895. PubMed ID: 29274030
[TBL] [Abstract] [Full Text] [Related]
8. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract] [Full Text] [Related]
9. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract] [Full Text] [Related]
10. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract] [Full Text] [Related]
11. Factors associated with diagnostic accuracy when performing a preablation renal biopsy.
Lorber G; Jorda M; Leveillee R
J Endourol; 2014 Dec; 28(12):1444-7. PubMed ID: 25299890
[TBL] [Abstract] [Full Text] [Related]
12. Distinguishing characteristics of urothelial carcinoma in kidney transplant recipients between China and Western countries.
Liu GM; Fang Q; Ma HS; Sun G; Wang XC
Transplant Proc; 2013; 45(6):2197-202. PubMed ID: 23747184
[TBL] [Abstract] [Full Text] [Related]
13. Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
Rini BI; Cohen DP; Lu DR; Chen I; Hariharan S; Gore ME; Figlin RA; Baum MS; Motzer RJ
J Natl Cancer Inst; 2011 May; 103(9):763-73. PubMed ID: 21527770
[TBL] [Abstract] [Full Text] [Related]
14. Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas.
Llacer-Moscardo C; Quenet F; Azria D; Fenoglietto P
Radiat Oncol; 2010 Sep; 5():83. PubMed ID: 20854661
[TBL] [Abstract] [Full Text] [Related]
15. Cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery.
Gutierrez JC; Koniaris LG; Cheung MC; Byrne MM; Fischer AC; Sola JE
Surgery; 2009 Jan; 145(1):76-85. PubMed ID: 19081478
[TBL] [Abstract] [Full Text] [Related]
16. [Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Jang BK; Lee SH; Chung WJ; Park KS; Cho KB; Hwang JS; Kim YH; Choi JS; Kwon JH
Korean J Hepatol; 2008 Jun; 14(2):168-77. PubMed ID: 18617764
[TBL] [Abstract] [Full Text] [Related]
17. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract] [Full Text] [Related]
18. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
Ito N; Eto M; Nakamura E; Takahashi A; Tsukamoto T; Toma H; Nakazawa H; Hirao Y; Uemura H; Kagawa S; Kanayama H; Nose Y; Kinukawa N; Nakamura T; Jinnai N; Seki T; Takamatsu M; Masui Y; Naito S; Ogawa O
J Clin Oncol; 2007 Jul; 25(19):2785-91. PubMed ID: 17602083
[TBL] [Abstract] [Full Text] [Related]
19. Experience and outcomes of nephroblastoma in Johannesburg, 1998 - 2003.
Rogers T; Bowley DM; Poole J; Swanepoel P; Wainwright J; Beale P; Pitcher G
Eur J Pediatr Surg; 2007 Feb; 17(1):41-4. PubMed ID: 17407020
[TBL] [Abstract] [Full Text] [Related]
20. [Intensive chemotherapy in the treatment of patients with metastatic breast cancer].
Salgado JE; Aramendía JM; Fernández-Hidalgo OA; Lozano E; Rebollo J; Martínez-Monge R; Subirá ML; Brugarolas A
Rev Med Univ Navarra; 1997; 41(3):143-51. PubMed ID: 10420919
[TBL] [Abstract] [Full Text] [Related]
[Next]
